BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson's disease

F. R. Guerini, E. Beghi, G. Riboldazzi, R. Zangaglia, C. Pianezzola, G. Bono, C. Casali, C. Di Lorenzo, C. Agliardi, G. Nappi, M. Clerici, E. Martignoni

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

Background and purpose: A possible association between Parkinson's disease (PD) and the polymorphism of Brain Derived Neurotrophic Factor (BDNF) G196A (Val66Met) has been suggested by different studies that nevertheless yielded-contrasting result. The purpose of this study was to analyze such possible association in a cohort of Italian PD patients. Methods: The BDNF polymorphisms were analyzed in 294 Italian patients with PD; results were compared to those obtained in 233 age- and sex-matched healthy controls (HC) enrolled from two tertiary centres in Italy. Polymorphisms were determined by Restriction Fragment Length Polymorphism (RFLP) analysis; correlations between BDNF G196A polymorphism, and cognitive function were established by sub analyzing the results upon dividing PD patients based on their Mini Mental State Examination (MMSE) score. Results: Univariate analysis showed a highly significant correlation between the BDNF(AA) genotype and a MMSE score ≤24. Hence, the distribution of this genotype in PD individuals with a MMSE score ≤24 was significantly increased compared to PD patients with an MMSE score >24 and HC (P <0.001 in both cases). Multivariate analyses showed that BDNF (AA) genotype was associated to a sixfold risk of cognitive impairment. Conclusions: The BDNF(AA) homozygote genotype is over-represented in PD patients compared with normal individuals; this genotype was significantly correlated to cognitive impairment, age and disease severity. These results, although preliminary, could be important in establishing novel diagnostic and therapeutic approaches to PD.

Original languageEnglish
Pages (from-to)1240-1245
Number of pages6
JournalEuropean Journal of Neurology
Volume16
Issue number11
DOIs
Publication statusPublished - Nov 2009

Fingerprint

Brain-Derived Neurotrophic Factor
Parkinson Disease
Genotype
Cognitive Dysfunction
Homozygote
Restriction Fragment Length Polymorphisms
Cognition
Italy
Multivariate Analysis

Keywords

  • Brain Derived Neurotrophic Factor
  • Mini Mental State Examination
  • Parkinson's disease

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson's disease. / Guerini, F. R.; Beghi, E.; Riboldazzi, G.; Zangaglia, R.; Pianezzola, C.; Bono, G.; Casali, C.; Di Lorenzo, C.; Agliardi, C.; Nappi, G.; Clerici, M.; Martignoni, E.

In: European Journal of Neurology, Vol. 16, No. 11, 11.2009, p. 1240-1245.

Research output: Contribution to journalArticle

@article{2863f014698d4a8a98ac4fad61b958cd,
title = "BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson's disease",
abstract = "Background and purpose: A possible association between Parkinson's disease (PD) and the polymorphism of Brain Derived Neurotrophic Factor (BDNF) G196A (Val66Met) has been suggested by different studies that nevertheless yielded-contrasting result. The purpose of this study was to analyze such possible association in a cohort of Italian PD patients. Methods: The BDNF polymorphisms were analyzed in 294 Italian patients with PD; results were compared to those obtained in 233 age- and sex-matched healthy controls (HC) enrolled from two tertiary centres in Italy. Polymorphisms were determined by Restriction Fragment Length Polymorphism (RFLP) analysis; correlations between BDNF G196A polymorphism, and cognitive function were established by sub analyzing the results upon dividing PD patients based on their Mini Mental State Examination (MMSE) score. Results: Univariate analysis showed a highly significant correlation between the BDNF(AA) genotype and a MMSE score ≤24. Hence, the distribution of this genotype in PD individuals with a MMSE score ≤24 was significantly increased compared to PD patients with an MMSE score >24 and HC (P <0.001 in both cases). Multivariate analyses showed that BDNF (AA) genotype was associated to a sixfold risk of cognitive impairment. Conclusions: The BDNF(AA) homozygote genotype is over-represented in PD patients compared with normal individuals; this genotype was significantly correlated to cognitive impairment, age and disease severity. These results, although preliminary, could be important in establishing novel diagnostic and therapeutic approaches to PD.",
keywords = "Brain Derived Neurotrophic Factor, Mini Mental State Examination, Parkinson's disease",
author = "Guerini, {F. R.} and E. Beghi and G. Riboldazzi and R. Zangaglia and C. Pianezzola and G. Bono and C. Casali and {Di Lorenzo}, C. and C. Agliardi and G. Nappi and M. Clerici and E. Martignoni",
year = "2009",
month = "11",
doi = "10.1111/j.1468-1331.2009.02706.x",
language = "English",
volume = "16",
pages = "1240--1245",
journal = "European Journal of Neurology",
issn = "1351-5101",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "11",

}

TY - JOUR

T1 - BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson's disease

AU - Guerini, F. R.

AU - Beghi, E.

AU - Riboldazzi, G.

AU - Zangaglia, R.

AU - Pianezzola, C.

AU - Bono, G.

AU - Casali, C.

AU - Di Lorenzo, C.

AU - Agliardi, C.

AU - Nappi, G.

AU - Clerici, M.

AU - Martignoni, E.

PY - 2009/11

Y1 - 2009/11

N2 - Background and purpose: A possible association between Parkinson's disease (PD) and the polymorphism of Brain Derived Neurotrophic Factor (BDNF) G196A (Val66Met) has been suggested by different studies that nevertheless yielded-contrasting result. The purpose of this study was to analyze such possible association in a cohort of Italian PD patients. Methods: The BDNF polymorphisms were analyzed in 294 Italian patients with PD; results were compared to those obtained in 233 age- and sex-matched healthy controls (HC) enrolled from two tertiary centres in Italy. Polymorphisms were determined by Restriction Fragment Length Polymorphism (RFLP) analysis; correlations between BDNF G196A polymorphism, and cognitive function were established by sub analyzing the results upon dividing PD patients based on their Mini Mental State Examination (MMSE) score. Results: Univariate analysis showed a highly significant correlation between the BDNF(AA) genotype and a MMSE score ≤24. Hence, the distribution of this genotype in PD individuals with a MMSE score ≤24 was significantly increased compared to PD patients with an MMSE score >24 and HC (P <0.001 in both cases). Multivariate analyses showed that BDNF (AA) genotype was associated to a sixfold risk of cognitive impairment. Conclusions: The BDNF(AA) homozygote genotype is over-represented in PD patients compared with normal individuals; this genotype was significantly correlated to cognitive impairment, age and disease severity. These results, although preliminary, could be important in establishing novel diagnostic and therapeutic approaches to PD.

AB - Background and purpose: A possible association between Parkinson's disease (PD) and the polymorphism of Brain Derived Neurotrophic Factor (BDNF) G196A (Val66Met) has been suggested by different studies that nevertheless yielded-contrasting result. The purpose of this study was to analyze such possible association in a cohort of Italian PD patients. Methods: The BDNF polymorphisms were analyzed in 294 Italian patients with PD; results were compared to those obtained in 233 age- and sex-matched healthy controls (HC) enrolled from two tertiary centres in Italy. Polymorphisms were determined by Restriction Fragment Length Polymorphism (RFLP) analysis; correlations between BDNF G196A polymorphism, and cognitive function were established by sub analyzing the results upon dividing PD patients based on their Mini Mental State Examination (MMSE) score. Results: Univariate analysis showed a highly significant correlation between the BDNF(AA) genotype and a MMSE score ≤24. Hence, the distribution of this genotype in PD individuals with a MMSE score ≤24 was significantly increased compared to PD patients with an MMSE score >24 and HC (P <0.001 in both cases). Multivariate analyses showed that BDNF (AA) genotype was associated to a sixfold risk of cognitive impairment. Conclusions: The BDNF(AA) homozygote genotype is over-represented in PD patients compared with normal individuals; this genotype was significantly correlated to cognitive impairment, age and disease severity. These results, although preliminary, could be important in establishing novel diagnostic and therapeutic approaches to PD.

KW - Brain Derived Neurotrophic Factor

KW - Mini Mental State Examination

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=70350134497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350134497&partnerID=8YFLogxK

U2 - 10.1111/j.1468-1331.2009.02706.x

DO - 10.1111/j.1468-1331.2009.02706.x

M3 - Article

C2 - 19538209

AN - SCOPUS:70350134497

VL - 16

SP - 1240

EP - 1245

JO - European Journal of Neurology

JF - European Journal of Neurology

SN - 1351-5101

IS - 11

ER -